110 related articles for article (PubMed ID: 1753388)
1. Hyporesponsiveness to a GnRH vaccine in a non-responder mouse strain is T-cell mediated.
Sad S; Gupta HM; Talwar GP; Raghupathy R
J Reprod Immunol; 1991 Jul; 20(2):189-94. PubMed ID: 1753388
[TBL] [Abstract][Full Text] [Related]
2. Carrier-induced suppression of the antibody response to a 'self' hapten.
Sad S; Gupta HM; Talwar GP; Raghupathy R
Immunology; 1991 Oct; 74(2):223-7. PubMed ID: 1748470
[TBL] [Abstract][Full Text] [Related]
3. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
[TBL] [Abstract][Full Text] [Related]
4. Influence of the genetic background and carrier protein on the antibody response to GnRH.
Sad S; Talwar GP; Raghupathy R
J Reprod Immunol; 1991 Feb; 19(2):197-207. PubMed ID: 2008003
[TBL] [Abstract][Full Text] [Related]
5. Synthetic gonadotrophin-releasing hormone (GnRH) vaccines incorporating GnRH and synthetic T-helper epitopes.
Sad S; Chauhan VS; Arunan K; Raghupathy R
Vaccine; 1993; 11(11):1145-50. PubMed ID: 7504380
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for control of fertility and hormone dependent cancers.
Talwar GP; Singh O; Pal R; Chatterjee N
Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
[TBL] [Abstract][Full Text] [Related]
7. Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine.
Ferro VA; Stimson WH
Vaccine; 1998 Jul; 16(11-12):1095-102. PubMed ID: 9682364
[TBL] [Abstract][Full Text] [Related]
8. The effect of active immunization against gonadotropin-releasing hormone on the ultrastructure of the rat ventral prostate.
Fürst J; Fiebiger E; Mack D; Frick J; Rovan E
Urol Res; 1994; 22(2):107-13. PubMed ID: 7974913
[TBL] [Abstract][Full Text] [Related]
9. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
[TBL] [Abstract][Full Text] [Related]
10. Effect of docetaxel chemotherapy on the activity of a gonadotropin releasing hormone vaccine in patients with advanced prostate cancer.
Triozzi PL; Bolger GB; Neidhart J; Rinehart JJ; Saleh M; Allen KO; Sellers S; Waddell MJ
Prostate; 2005 Dec; 65(4):316-21. PubMed ID: 16015596
[TBL] [Abstract][Full Text] [Related]
11. Effect of immunisation against gonadotrophin releasing hormone isoforms (mammalian GnRH-I, chicken GnRH-II and lamprey GnRH-III) on murine spermatogenesis.
Khan MA; Prevost M; Waterston MM; Harvey MJ; Ferro VA
Vaccine; 2007 Mar; 25(11):2051-63. PubMed ID: 17240004
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines.
Tontini M; Berti F; Romano MR; Proietti D; Zambonelli C; Bottomley MJ; De Gregorio E; Del Giudice G; Rappuoli R; Costantino P; ; Brogioni G; Balocchi C; Biancucci M; Malito E
Vaccine; 2013 Oct; 31(42):4827-33. PubMed ID: 23965218
[TBL] [Abstract][Full Text] [Related]
13. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer.
Simms MS; Scholfield DP; Jacobs E; Michaeli D; Broome P; Humphreys JE; Bishop MC
Br J Cancer; 2000 Aug; 83(4):443-6. PubMed ID: 10945488
[TBL] [Abstract][Full Text] [Related]
14. Anti-fertility vaccines.
Talwar GP; Raghupathy R
Vaccine; 1989 Apr; 7(2):97-101. PubMed ID: 2665354
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs.
Earl ER; Waterston MM; Aughey E; Harvey MJ; Matschke C; Colston A; Ferro VA
Vaccine; 2006 Apr; 24(16):3172-83. PubMed ID: 16483697
[TBL] [Abstract][Full Text] [Related]
16. Novel Sperm and Gonadotropin-releasing Hormone-based Recombinant Fusion Protein: Achievement of 100% Contraceptive Efficacy by Co-immunization of Male and Female Mice.
Minhas V; Shrestha A; Wadhwa N; Singh R; Gupta SK
Mol Reprod Dev; 2016 Dec; 83(12):1048-1059. PubMed ID: 27676172
[TBL] [Abstract][Full Text] [Related]
17. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
[TBL] [Abstract][Full Text] [Related]
18. Chronic toxicity and reversibility of antifertility effect of immunization against gonadotropin-releasing hormone in male rats and rabbits.
Kumar N; Savage T; DeJesus W; Tsong YY; Didolkar A; Sundaram K
Toxicol Sci; 2000 Jan; 53(1):92-9. PubMed ID: 10653526
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms.
Junco JA; Basalto R; Fuentes F; Bover E; Reyes O; Pimentel E; Calzada L; Castro MD; Arteaga N; López Y; Hernández H; Bringas R; Garay H; Peschke P; Bertot J; Guillén G
Adv Exp Med Biol; 2008; 617():581-7. PubMed ID: 18497085
[TBL] [Abstract][Full Text] [Related]
20. Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant.
Mandokhot A; Pal R; Nagpal S; Chauhan VS; Ahlawat S; Singh O
Clin Exp Immunol; 2000 Oct; 122(1):101-8. PubMed ID: 11012625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
